Rab18 Is Reduced in Pituitary Tumors Causing Acromegaly and Its Overexpression Reverts Growth Hormone Hypersecretion
Context: Rab proteins regulate the sequential steps of intracellular membrane transport. Alterations of these GTPases and their associated proteins are emerging as the underlying cause for several human diseases involving dysregulated secretory activities. Objective: Herein we investigated the role...
Saved in:
Published in | The journal of clinical endocrinology and metabolism Vol. 93; no. 6; pp. 2269 - 2276 |
---|---|
Main Authors | , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Bethesda, MD
Endocrine Society
01.06.2008
Copyright by The Endocrine Society |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Context: Rab proteins regulate the sequential steps of intracellular membrane transport. Alterations of these GTPases and their associated proteins are emerging as the underlying cause for several human diseases involving dysregulated secretory activities.
Objective: Herein we investigated the role of Rab18, which negatively regulates hormone secretion by interacting with secretory granules, in relation to the altered functioning of tumoral pituitary somatotropes causing acromegaly.
Patients: A total of 18 patients diagnosed with pituitary tumors causing acromegaly (nine patients) or nonfunctioning adenomas (nine patients) underwent endoscopic transsphenoidal surgery. Adenomas were subsequently processed to evaluate Rab18 production in relation to GH secretion.
Results: We found that somatotropinoma cells are characterized by a high secretory activity concomitantly with a remarkably reduced Rab18 expression (15%) and protein content levels (30%), as compared with cells from nonfunctioning pituitary adenomas derived from patients with normal or reduced GH plasma levels (100%). Furthermore, immunoelectron microscopy revealed that Rab18 association with the surface of GH-containing secretory granules was significantly lower in somatotropes from acromegalies than nonfunctioning pituitary adenomas. Finally, we provide evidence that modulation of Rab18 gene expression can revert substantially the hypersecretory activity of cells because Rab18 overexpression reduced by 40% the capacity of cells from acromegalies to respond to GHRH stimulation.
Conclusion: These results suggest that molecular alterations affecting individual components of the secretory granule traffic machinery can contribute to maintain a high level of GH in plasma. Accordingly, Rab18 constitutes a valuable target as a diagnostic, prognostic, and/or therapeutic tool for human acromegaly. |
---|---|
AbstractList | Context: Rab proteins regulate the sequential steps of intracellular membrane transport. Alterations of these GTPases and their associated proteins are emerging as the underlying cause for several human diseases involving dysregulated secretory activities.
Objective: Herein we investigated the role of Rab18, which negatively regulates hormone secretion by interacting with secretory granules, in relation to the altered functioning of tumoral pituitary somatotropes causing acromegaly.
Patients: A total of 18 patients diagnosed with pituitary tumors causing acromegaly (nine patients) or nonfunctioning adenomas (nine patients) underwent endoscopic transsphenoidal surgery. Adenomas were subsequently processed to evaluate Rab18 production in relation to GH secretion.
Results: We found that somatotropinoma cells are characterized by a high secretory activity concomitantly with a remarkably reduced Rab18 expression (15%) and protein content levels (30%), as compared with cells from nonfunctioning pituitary adenomas derived from patients with normal or reduced GH plasma levels (100%). Furthermore, immunoelectron microscopy revealed that Rab18 association with the surface of GH-containing secretory granules was significantly lower in somatotropes from acromegalies than nonfunctioning pituitary adenomas. Finally, we provide evidence that modulation of Rab18 gene expression can revert substantially the hypersecretory activity of cells because Rab18 overexpression reduced by 40% the capacity of cells from acromegalies to respond to GHRH stimulation.
Conclusion: These results suggest that molecular alterations affecting individual components of the secretory granule traffic machinery can contribute to maintain a high level of GH in plasma. Accordingly, Rab18 constitutes a valuable target as a diagnostic, prognostic, and/or therapeutic tool for human acromegaly. CONTEXTRab proteins regulate the sequential steps of intracellular membrane transport. Alterations of these GTPases and their associated proteins are emerging as the underlying cause for several human diseases involving dysregulated secretory activities.OBJECTIVEHerein we investigated the role of Rab18, which negatively regulates hormone secretion by interacting with secretory granules, in relation to the altered functioning of tumoral pituitary somatotropes causing acromegaly.PATIENTSA total of 18 patients diagnosed with pituitary tumors causing acromegaly (nine patients) or nonfunctioning adenomas (nine patients) underwent endoscopic transsphenoidal surgery. Adenomas were subsequently processed to evaluate Rab18 production in relation to GH secretion.RESULTSWe found that somatotropinoma cells are characterized by a high secretory activity concomitantly with a remarkably reduced Rab18 expression (15%) and protein content levels (30%), as compared with cells from nonfunctioning pituitary adenomas derived from patients with normal or reduced GH plasma levels (100%). Furthermore, immunoelectron microscopy revealed that Rab18 association with the surface of GH-containing secretory granules was significantly lower in somatotropes from acromegalies than nonfunctioning pituitary adenomas. Finally, we provide evidence that modulation of Rab18 gene expression can revert substantially the hypersecretory activity of cells because Rab18 overexpression reduced by 40% the capacity of cells from acromegalies to respond to GHRH stimulation.CONCLUSIONThese results suggest that molecular alterations affecting individual components of the secretory granule traffic machinery can contribute to maintain a high level of GH in plasma. Accordingly, Rab18 constitutes a valuable target as a diagnostic, prognostic, and/or therapeutic tool for human acromegaly. CONTEXT: Rab proteins regulate the sequential steps of intracellular membrane transport. Alterations of these GTPases and their associated proteins are emerging as the underlying cause for several human diseases involving dysregulated secretory activities. OBJECTIVE: Herein we investigated the role of Rab18, which negatively regulates hormone secretion by interacting with secretory granules, in relation to the altered functioning of tumoral pituitary somatotropes causing acromegaly. PATIENTS: A total of 18 patients diagnosed with pituitary tumors causing acromegaly (nine patients) or nonfunctioning adenomas (nine patients) underwent endoscopic transsphenoidal surgery. Adenomas were subsequently processed to evaluate Rab18 production in relation to GH secretion. RESULTS: We found that somatotropinoma cells are characterized by a high secretory activity concomitantly with a remarkably reduced Rab18 expression (15%) and protein content levels (30%), as compared with cells from nonfunctioning pituitary adenomas derived from patients with normal or reduced GH plasma levels (100%). Furthermore, immunoelectron microscopy revealed that Rab18 association with the surface of GH-containing secretory granules was significantly lower in somatotropes from acromegalies than nonfunctioning pituitary adenomas. Finally, we provide evidence that modulation of Rab18 gene expression can revert substantially the hypersecretory activity of cells because Rab18 overexpression reduced by 40% the capacity of cells from acromegalies to respond to GHRH stimulation. CONCLUSION: These results suggest that molecular alterations affecting individual components of the secretory granule traffic machinery can contribute to maintain a high level of GH in plasma. Accordingly, Rab18 constitutes a valuable target as a diagnostic, prognostic, and/or therapeutic tool for human acromegaly. Rab proteins regulate the sequential steps of intracellular membrane transport. Alterations of these GTPases and their associated proteins are emerging as the underlying cause for several human diseases involving dysregulated secretory activities. Herein we investigated the role of Rab18, which negatively regulates hormone secretion by interacting with secretory granules, in relation to the altered functioning of tumoral pituitary somatotropes causing acromegaly. A total of 18 patients diagnosed with pituitary tumors causing acromegaly (nine patients) or nonfunctioning adenomas (nine patients) underwent endoscopic transsphenoidal surgery. Adenomas were subsequently processed to evaluate Rab18 production in relation to GH secretion. We found that somatotropinoma cells are characterized by a high secretory activity concomitantly with a remarkably reduced Rab18 expression (15%) and protein content levels (30%), as compared with cells from nonfunctioning pituitary adenomas derived from patients with normal or reduced GH plasma levels (100%). Furthermore, immunoelectron microscopy revealed that Rab18 association with the surface of GH-containing secretory granules was significantly lower in somatotropes from acromegalies than nonfunctioning pituitary adenomas. Finally, we provide evidence that modulation of Rab18 gene expression can revert substantially the hypersecretory activity of cells because Rab18 overexpression reduced by 40% the capacity of cells from acromegalies to respond to GHRH stimulation. These results suggest that molecular alterations affecting individual components of the secretory granule traffic machinery can contribute to maintain a high level of GH in plasma. Accordingly, Rab18 constitutes a valuable target as a diagnostic, prognostic, and/or therapeutic tool for human acromegaly. Abstract Context: Rab proteins regulate the sequential steps of intracellular membrane transport. Alterations of these GTPases and their associated proteins are emerging as the underlying cause for several human diseases involving dysregulated secretory activities. Objective: Herein we investigated the role of Rab18, which negatively regulates hormone secretion by interacting with secretory granules, in relation to the altered functioning of tumoral pituitary somatotropes causing acromegaly. Patients: A total of 18 patients diagnosed with pituitary tumors causing acromegaly (nine patients) or nonfunctioning adenomas (nine patients) underwent endoscopic transsphenoidal surgery. Adenomas were subsequently processed to evaluate Rab18 production in relation to GH secretion. Results: We found that somatotropinoma cells are characterized by a high secretory activity concomitantly with a remarkably reduced Rab18 expression (15%) and protein content levels (30%), as compared with cells from nonfunctioning pituitary adenomas derived from patients with normal or reduced GH plasma levels (100%). Furthermore, immunoelectron microscopy revealed that Rab18 association with the surface of GH-containing secretory granules was significantly lower in somatotropes from acromegalies than nonfunctioning pituitary adenomas. Finally, we provide evidence that modulation of Rab18 gene expression can revert substantially the hypersecretory activity of cells because Rab18 overexpression reduced by 40% the capacity of cells from acromegalies to respond to GHRH stimulation. Conclusion: These results suggest that molecular alterations affecting individual components of the secretory granule traffic machinery can contribute to maintain a high level of GH in plasma. Accordingly, Rab18 constitutes a valuable target as a diagnostic, prognostic, and/or therapeutic tool for human acromegaly. |
Author | Leal-Cerro, Alfonso Sucunza, Nuria Malagon, Maria M Galvez-Moreno, Maria A Bartumeus, Frederic Martinez-Fuentes, Antonio J Benito-Lopez, Pedro Castaño, Justo P Quintero, Ana Pulido, Marina R Vazquez-Martinez, Rafael Webb, Susan M Soto, Alfonso Jimenez-Reina, Luis |
AuthorAffiliation | Department of Cell Biology, Physiology, and Immunology (R.V.-M., A.J.M.-F., M.R.P., A.Q., J.P.C., M.M.M.), University of Cordoba, Centros de Investigacion Biomedica en Red (CIBER) Obesidad y Nutricion (R.V.-M., A.J.M.-F., M.R.P., A.Q., J.P.C., M.M.M.), Instituto Carlos III, and Department of Morphological Sciences (L.J.-R.), University of Cordoba, E-14014, Cordoba, Spain; Division of Endocrinology (A.L.-C., A.S.), Virgen del Rocio University Hospital, E-41013 Sevilla, Spain; Department of Endocrinology (S.M.W., N.S.), Center for Biomedical Research on Rare Diseases (CIBER U747), and Service of Neurosurgery (F.B.), Sant Pau Hospital, Autonomous University of Barcelona, E-08025 Barcelona, Spain; and Service of Endocrinology and Nutrition (P.B.-L., M.A.G.-M.), Reina Sofia Hospital, E-14004 Cordoba, Spain |
AuthorAffiliation_xml | – name: Department of Cell Biology, Physiology, and Immunology (R.V.-M., A.J.M.-F., M.R.P., A.Q., J.P.C., M.M.M.), University of Cordoba, Centros de Investigacion Biomedica en Red (CIBER) Obesidad y Nutricion (R.V.-M., A.J.M.-F., M.R.P., A.Q., J.P.C., M.M.M.), Instituto Carlos III, and Department of Morphological Sciences (L.J.-R.), University of Cordoba, E-14014, Cordoba, Spain; Division of Endocrinology (A.L.-C., A.S.), Virgen del Rocio University Hospital, E-41013 Sevilla, Spain; Department of Endocrinology (S.M.W., N.S.), Center for Biomedical Research on Rare Diseases (CIBER U747), and Service of Neurosurgery (F.B.), Sant Pau Hospital, Autonomous University of Barcelona, E-08025 Barcelona, Spain; and Service of Endocrinology and Nutrition (P.B.-L., M.A.G.-M.), Reina Sofia Hospital, E-14004 Cordoba, Spain |
Author_xml | – sequence: 1 givenname: Rafael surname: Vazquez-Martinez fullname: Vazquez-Martinez, Rafael – sequence: 2 givenname: Antonio J surname: Martinez-Fuentes fullname: Martinez-Fuentes, Antonio J – sequence: 3 givenname: Marina R surname: Pulido fullname: Pulido, Marina R – sequence: 4 givenname: Luis surname: Jimenez-Reina fullname: Jimenez-Reina, Luis – sequence: 5 givenname: Ana surname: Quintero fullname: Quintero, Ana – sequence: 6 givenname: Alfonso surname: Leal-Cerro fullname: Leal-Cerro, Alfonso – sequence: 7 givenname: Alfonso surname: Soto fullname: Soto, Alfonso – sequence: 8 givenname: Susan M surname: Webb fullname: Webb, Susan M – sequence: 9 givenname: Nuria surname: Sucunza fullname: Sucunza, Nuria – sequence: 10 givenname: Frederic surname: Bartumeus fullname: Bartumeus, Frederic – sequence: 11 givenname: Pedro surname: Benito-Lopez fullname: Benito-Lopez, Pedro – sequence: 12 givenname: Maria A surname: Galvez-Moreno fullname: Galvez-Moreno, Maria A – sequence: 13 givenname: Justo P surname: Castaño fullname: Castaño, Justo P – sequence: 14 givenname: Maria M surname: Malagon fullname: Malagon, Maria M |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20405754$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/18349058$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc1vEzEQxS1URNPAjTPyBU5s8efae6wiaCJVKqqKxM1yvLPNhl072GtC_nscEsEFCR9szeg3z6P3rtCFDx4Qek3JNWWUfNi6a0aIqqhu-DM0o42QlaKNukAzQhitGsW-XqKrlLaEUCEkf4EuqeaiIVLP0PRg11TjVcIP0GYHLe49_txPuZ9sPODHPIaY8MLm1PsnfONiGOHJDgdsfYtXU8L3PyDCz12ElPrgi0qpS_s2hv20wcsQx7IuXh52EBO4CFOhXqLnnR0SvDq_c_Tl08fHxbK6u79dLW7uKieUIpVy1ja1dqrcLdfKdQ4kEZLWVgKTouVMWEFrTrvWUu1kxx1V1NZrzrRWjM_Ru5PuLobvGdJkxj45GAbrIeRkFK1lQzT9L8iILhsV1-bo_QksRqQUoTO72I_FKUOJOcZhts4c4zDHOAr-5qyb1yO0f-Gz_wV4ewZscnboovWuT384RgSRSorCiRO3D8NUnPw25D1EswE7TBtDyhG10lX5WZO6VNWxQ8oYP42Bb4OLvYffQZltyNEX5_-99S-YbLUn |
CODEN | JCEMAZ |
CitedBy_id | crossref_primary_10_1007_s40618_019_01178_4 crossref_primary_10_1016_j_ajhg_2013_10_011 crossref_primary_10_1002_humu_22296 crossref_primary_10_1016_j_biomaterials_2013_11_003 crossref_primary_10_1210_en_2014_1034 crossref_primary_10_1016_j_bcmd_2012_05_002 crossref_primary_10_1016_j_plaphy_2017_01_025 crossref_primary_10_1016_j_ajhg_2011_03_012 crossref_primary_10_1007_s12032_014_0859_x crossref_primary_10_1016_j_mce_2011_11_005 crossref_primary_10_1155_2021_9923454 crossref_primary_10_1530_JOE_16_0332 crossref_primary_10_1007_s00125_016_4155_5 crossref_primary_10_1111_j_1749_6632_2008_03654_x crossref_primary_10_1016_j_bbamcr_2016_01_004 crossref_primary_10_1016_j_bbalip_2021_158923 crossref_primary_10_1016_j_gene_2016_07_034 crossref_primary_10_1016_j_biocel_2018_03_002 |
Cites_doi | 10.1210/jcem.83.2.4556 10.1126/science.1066901 10.1016/S1471-4914(01)02227-4 10.1158/0008-5472.CAN-05-0573 10.1056/NEJMra021405 10.1146/annurev.neuro.22.1.1 10.1073/pnas.122187699 10.1002/ijc.11208 10.1210/jc.2002-011841 10.1086/367847 10.1016/S0140-6736(01)06844-1 10.1056/NEJMra062453 10.1210/jc.2002-020072 10.1038/nm1125 10.1016/S0014-5793(99)01778-0 10.1210/jcem.83.10.5111 10.1007/BF03347721 10.1016/j.cell.2007.03.053 10.1056/NEJM200004203421604 10.1080/10425170500061681 10.1177/40.11.1358942 10.1111/j.1600-0854.2007.00570.x 10.1056/NEJM197911223012102 10.1038/76024 10.1006/gcen.2002.7778 10.1210/jc.2006-0235 10.1210/jc.2006-1668 10.1038/35052055 10.1210/jcem-71-6-1421 10.1530/eje.0.1390516 |
ContentType | Journal Article |
Copyright | Copyright © 2008 by The Endocrine Society 2008 INIST-CNRS |
Copyright_xml | – notice: Copyright © 2008 by The Endocrine Society – notice: 2008 INIST-CNRS |
DBID | IQODW CGR CUY CVF ECM EIF NPM AAYXX CITATION 7TK 7X8 |
DOI | 10.1210/jc.2007-1893 |
DatabaseName | Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Neurosciences Abstracts MEDLINE - Academic |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef Neurosciences Abstracts MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic Neurosciences Abstracts MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1945-7197 |
EndPage | 2276 |
ExternalDocumentID | 10_1210_jc_2007_1893 18349058 20405754 00004678-200806000-00040 |
Genre | Multicenter Study Comparative Study Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | - 02 08R 0R 1TH 29K 2WC 34G 39C 3O- 3V. 4.4 48X 53G 55 5GY 5RS 5YH 7X7 88E 8F7 8FI 8FJ AABJS AABMN AAIMJ AAJQQ AAPQZ AAQQT AAUQX AAWTL AAYJJ ABFLS ABOCM ABPMR ABPPZ ABSAR ABUWG ACGFS ACIMA ACPRK ACUTJ ADBBV ADBIT ADEIU ADGZP ADHKW ADRTK AELNO AELWJ AEMDU AENEX AENZO AETBJ AEWNT AFCHL AFFNX AFKRA AFRAH AFXEN AGINJ AGKRT AGVJH AHMBA AIKOY AIMBJ ALMA_UNASSIGNED_HOLDINGS APIBT AQKUS ARIXL ASMCH ASPBG AVWKF AYOIW AZFZN AZQFJ BAWUL BAYMD BBAFP BCRHZ BENPR BEYMZ BGYMP BHONS BPHCQ BSWAC BTRTY BVXVI C45 CDBKE CS3 D-I DAKXR DIK DPPUQ E3Z EBS EIHJH EJD ENERS F5P FEDTE FH7 FHSFR FOTVD FQBLK FYUFA G8K GAUVT GJ GJXCC GX1 H1 H13 HVGLF HZ H~9 IAO IHR INH J5H KBUDW KOP KQ8 KSN L7B M1P M5 MBLQV MHKGH N9A NLBLG NOYVH NVLIB O0- O9- OBH OCB ODMLO OGEVE OK1 OVD P2P PQEST PQQKQ PQUKI PRINS PROAC PSQYO REU ROX ROZ TCN TJX TLC TMA TWZ VH1 WOQ X X52 X7M XZ ZA5 ZGI ZXP ZY1 .XZ 3RD AJYGW M2M M5~ ROL ~H1 --- -~X .55 .GJ 08P 0R~ 18M 354 AABZA AACZT AAKAS AAPGJ AAPXW AAUGY AAVAP AAWDT ABBLC ABLJU ABPQP ABPTD ABWST ABXZS ACFRR ACGFO ACYHN ADGKP ADVEK ADZCM AERZD AFFZL AFGWE AFOFC AFXAL AFYAG AGQXC AGUTN AI. AJEEA ALXQX APJGH AQDSO BYORX CASEJ EMOBN FECEO FLUFQ FOEOM HZ~ IQODW KSI MJL N4W NOMLY OAUYM OBFPC OFXIZ OHH OPAEJ OVIDX P6G TEORI TR2 VVN W8F WHG YBU YFH YHG YOC YSK ~02 AARHZ AAUAY ABJNI ABMNT ABNHQ ABQNK ABXVV ACZBC ADQBN AGMDO ATGXG AVNTJ CGR CUY CVF ECM EIF ITC NPM OJZSN AAYXX CITATION 7TK 7X8 |
ID | FETCH-LOGICAL-c4770-7caa968c7a96d387cfce504516a5e254d324a41631fda18c5f3c171a6b3288723 |
ISSN | 0021-972X |
IngestDate | Fri Oct 25 11:24:10 EDT 2024 Fri Oct 25 01:07:25 EDT 2024 Thu Sep 12 16:26:16 EDT 2024 Sat Sep 28 07:44:16 EDT 2024 Sun Oct 22 16:06:53 EDT 2023 Thu Aug 13 19:45:25 EDT 2020 Tue Jan 05 21:44:38 EST 2021 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 6 |
Keywords | Endocrinopathy Obesity Endocrine gland Nutrition Diseases of the osteoarticular system Nutrition disorder Acromegaly Gene overexpression Metabolic diseases Hypersecretion Somatotropin Reduction Adenohypophyseal hormone Pituitary diseases Pituitary gland Tumor Endocrinology Nutritional status |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c4770-7caa968c7a96d387cfce504516a5e254d324a41631fda18c5f3c171a6b3288723 |
Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 ObjectType-Article-1 ObjectType-Feature-2 |
OpenAccessLink | https://academic.oup.com/jcem/article-pdf/93/6/2269/9057233/jcem2269.pdf |
PMID | 18349058 |
PQID | 20847718 |
PQPubID | 23462 |
PageCount | 8 |
ParticipantIDs | proquest_miscellaneous_71659081 proquest_miscellaneous_20847718 crossref_primary_10_1210_jc_2007_1893 pubmed_primary_18349058 pascalfrancis_primary_20405754 wolterskluwer_health_00004678-200806000-00040 endocrinepress_journals_10_1210_jc_2007_1893 |
ProviderPackageCode | .XZ OBH C45 5RS AFCHL OGEVE ~H1 ABPMR M5~ OVD OCB |
PublicationCentury | 2000 |
PublicationDate | 2008-June |
PublicationDateYYYYMMDD | 2008-06-01 |
PublicationDate_xml | – month: 06 year: 2008 text: 2008-June |
PublicationDecade | 2000 |
PublicationPlace | Bethesda, MD |
PublicationPlace_xml | – name: Bethesda, MD – name: United States |
PublicationTitle | The journal of clinical endocrinology and metabolism |
PublicationTitleAlternate | J Clin Endocrinol Metab |
PublicationYear | 2008 |
Publisher | Endocrine Society Copyright by The Endocrine Society |
Publisher_xml | – name: Endocrine Society – name: Copyright by The Endocrine Society |
References | Melmed (2020071613155272600_R7) 1998; 83 Taupenot (2020071613155272600_R32) 2003; 348 Melmed (2020071613155272600_R1) 2002; 87 Nachury (2020071613155272600_R20) 2007; 129 Melmed (2020071613155272600_R3) 2006; 355 Seabra (2020071613155272600_R18) 2002; 8 Martinez-Fuentes (2020071613155272600_R28) 2006; 91 Spada (2020071613155272600_R33) 1990; 71 Daly (2020071613155272600_R2) 2005; 28 Colao (2020071613155272600_R15) 2003; 26 Ben-Shlomo (2020071613155272600_R10) 2003; 88 Clemmons (2020071613155272600_R5) 1979; 301 Dobado-Berrios (2020071613155272600_R29) 1992; 40 Schafer (2020071613155272600_R35) 2000; 466 Cozzi (2020071613155272600_R11) 1998; 139 Colao (2020071613155272600_R37) 2001; 86 Zerial (2020071613155272600_R16) 2001; 2 Cheng (2020071613155272600_R24) 2004; 10 Rosa (2020071613155272600_R31) 1994; 17 Peinado (2020071613155272600_R27) 2002; 126 Cochilla (2020071613155272600_R30) 1999; 22 Pei (2020071613155272600_R22) 2002; 62 Behrends (2020071613155272600_R36) 2003; 106 Swearingen (2020071613155272600_R6) 1998; 83 Menasche (2020071613155272600_R17) 2000; 25 Cheng (2020071613155272600_R25) 2005; 65 Trainer (2020071613155272600_R13) 2000; 342 van der Lely (2020071613155272600_R14) 2001; 358 Daly (2020071613155272600_R4) 2006; 91 Rezaie (2020071613155272600_R21) 2002; 295 Vazquez-Martinez (2020071613155272600_R26) 2007; 8 Dou (2020071613155272600_R34) 2005; 16 Verhoeven (2020071613155272600_R19) 2003; 72 Holdaway (2020071613155272600_R8) 2004; 62 Abosch (2020071613155272600_R9) 1998; 83 Croizet-Berger (2020071613155272600_R23) 2002; 99 Abs (2020071613155272600_R12) 1998; 83 |
References_xml | – volume: 83 start-page: 374 year: 1998 ident: 2020071613155272600_R12 article-title: Cabergoline in the treatment of acromegaly: a study in 64 patients. publication-title: J Clin Endocrinol Metab doi: 10.1210/jcem.83.2.4556 contributor: fullname: Abs – volume: 295 start-page: 1077 year: 2002 ident: 2020071613155272600_R21 article-title: Adult-onset primary open-angle glaucoma caused by mutations in optineurin. publication-title: Science doi: 10.1126/science.1066901 contributor: fullname: Rezaie – volume: 8 start-page: 23 year: 2002 ident: 2020071613155272600_R18 article-title: Rab GTPases, intracellular traffic and disease. publication-title: Trends Mol Med doi: 10.1016/S1471-4914(01)02227-4 contributor: fullname: Seabra – volume: 65 start-page: 2516 year: 2005 ident: 2020071613155272600_R25 article-title: Emerging role of RAB GTPases in cancer and human disease. publication-title: Cancer Res doi: 10.1158/0008-5472.CAN-05-0573 contributor: fullname: Cheng – volume: 348 start-page: 1134 year: 2003 ident: 2020071613155272600_R32 article-title: The chromogranin-secretogranin family. publication-title: N Engl J Med doi: 10.1056/NEJMra021405 contributor: fullname: Taupenot – volume: 22 start-page: 1 year: 1999 ident: 2020071613155272600_R30 article-title: Monitoring secretory membrane with FM1–43 fluorescence. publication-title: Annu Rev Neurosci doi: 10.1146/annurev.neuro.22.1.1 contributor: fullname: Cochilla – volume: 99 start-page: 8277 year: 2002 ident: 2020071613155272600_R23 article-title: The endocytic catalysts, Rab5a and Rab7, are tandem regulators of thyroid hormone production. publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.122187699 contributor: fullname: Croizet-Berger – volume: 106 start-page: 244 year: 2003 ident: 2020071613155272600_R36 article-title: Novel tumor antigens identified by autologous antibody screening of childhood medulloblastoma cDNA libraries. publication-title: Int J Cancer doi: 10.1002/ijc.11208 contributor: fullname: Behrends – volume: 87 start-page: 4054 year: 2002 ident: 2020071613155272600_R1 article-title: Guidelines for acromegaly management. publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2002-011841 contributor: fullname: Melmed – volume: 72 start-page: 722 year: 2003 ident: 2020071613155272600_R19 article-title: Mutations in the small GTP-ase late endosomal protein RAB7 cause Charcot-Marie-Tooth type 2B neuropathy. publication-title: Am J Hum Genet doi: 10.1086/367847 contributor: fullname: Verhoeven – volume: 358 start-page: 1754 year: 2001 ident: 2020071613155272600_R14 article-title: Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. publication-title: Lancet doi: 10.1016/S0140-6736(01)06844-1 contributor: fullname: van der Lely – volume: 83 start-page: 3419 year: 1998 ident: 2020071613155272600_R6 article-title: Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. publication-title: J Clin Endocrinol Metab contributor: fullname: Swearingen – volume: 355 start-page: 2558 year: 2006 ident: 2020071613155272600_R3 article-title: Medical progress: Acromegaly. publication-title: N Engl J Med doi: 10.1056/NEJMra062453 contributor: fullname: Melmed – volume: 88 start-page: 963 year: 2003 ident: 2020071613155272600_R10 article-title: Clinical review 154: the role of pharmacotherapy in perioperative management of patients with acromegaly. publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2002-020072 contributor: fullname: Ben-Shlomo – volume: 83 start-page: 2646 year: 1998 ident: 2020071613155272600_R7 article-title: Current treatment guidelines for acromegaly. publication-title: J Clin Endocrinol Metab contributor: fullname: Melmed – volume: 10 start-page: 1251 year: 2004 ident: 2020071613155272600_R24 article-title: The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers. publication-title: Nat Med doi: 10.1038/nm1125 contributor: fullname: Cheng – volume: 466 start-page: 148 year: 2000 ident: 2020071613155272600_R35 article-title: Isolation and characterisation of the human rab18 gene after stimulation of endothelial cells with histamine. publication-title: FEBS Lett doi: 10.1016/S0014-5793(99)01778-0 contributor: fullname: Schafer – volume: 83 start-page: 3411 year: 1998 ident: 2020071613155272600_R9 article-title: Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results. publication-title: J Clin Endocrinol Metab doi: 10.1210/jcem.83.10.5111 contributor: fullname: Abosch – volume: 17 start-page: 207 year: 1994 ident: 2020071613155272600_R31 article-title: The granin protein family: markers for neuroendocrine cells and tools for the diagnosis of neuroendocrine tumors. publication-title: J Endocrinol Invest doi: 10.1007/BF03347721 contributor: fullname: Rosa – volume: 26 start-page: 53 year: 2003 ident: 2020071613155272600_R15 article-title: The use of a GH receptor antagonist in patients with acromegaly resistant to somatostatin analogs. publication-title: J Endocrinol Invest contributor: fullname: Colao – volume: 129 start-page: 1201 year: 2007 ident: 2020071613155272600_R20 article-title: A core complex of BBS proteins cooperates with the GTPase Rab8 to promote ciliary membrane biogenesis. publication-title: Cell doi: 10.1016/j.cell.2007.03.053 contributor: fullname: Nachury – volume: 62 start-page: 79 issue: Suppl 3 year: 2004 ident: 2020071613155272600_R8 article-title: Treatment of acromegaly publication-title: Horm Res contributor: fullname: Holdaway – volume: 28 start-page: 67 year: 2005 ident: 2020071613155272600_R2 article-title: An overview of the epidemiology and genetics of acromegaly. publication-title: J Endocrinol Invest contributor: fullname: Daly – volume: 342 start-page: 1171 year: 2000 ident: 2020071613155272600_R13 article-title: Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. publication-title: N Engl J Med doi: 10.1056/NEJM200004203421604 contributor: fullname: Trainer – volume: 16 start-page: 230 year: 2005 ident: 2020071613155272600_R34 article-title: Cloning and characterization of a novel splice variant of human Rab18 gene (RAB18)dagger. publication-title: DNA Seq doi: 10.1080/10425170500061681 contributor: fullname: Dou – volume: 40 start-page: 1715 year: 1992 ident: 2020071613155272600_R29 article-title: Application of an optimized immunostaining technique to evaluate the heterogeneous secretory response from porcine somatotropes by cell blotting. publication-title: J Histochem Cytochem doi: 10.1177/40.11.1358942 contributor: fullname: Dobado-Berrios – volume: 86 start-page: 2779 year: 2001 ident: 2020071613155272600_R37 article-title: Long-term effects of depot long-acting somatostatin analog octreotide on hormone levels and tumor mass in acromegaly. publication-title: J Clin Endocrinol Metab contributor: fullname: Colao – volume: 8 start-page: 867 year: 2007 ident: 2020071613155272600_R26 article-title: Rab18 inhibits secretory activity in neuroendocrine cells by interacting with secretory granules. publication-title: Traffic doi: 10.1111/j.1600-0854.2007.00570.x contributor: fullname: Vazquez-Martinez – volume: 301 start-page: 1138 year: 1979 ident: 2020071613155272600_R5 article-title: Evaluation of acromegaly by radioimmunoassay of somatomedin-C. publication-title: N Engl J Med doi: 10.1056/NEJM197911223012102 contributor: fullname: Clemmons – volume: 62 start-page: 5420 year: 2002 ident: 2020071613155272600_R22 article-title: PRC17, a novel oncogene encoding a Rab GTPase-activating protein, is amplified in prostate cancer. publication-title: Cancer Res contributor: fullname: Pei – volume: 25 start-page: 173 year: 2000 ident: 2020071613155272600_R17 article-title: Mutations in RAB27A cause Griscelli syndrome associated with haemophagocytic syndrome. publication-title: Nat Genet doi: 10.1038/76024 contributor: fullname: Menasche – volume: 126 start-page: 4 year: 2002 ident: 2020071613155272600_R27 article-title: Amphibian melanotrophs as a model to analyze the secretory plasticity of endocrine cells. publication-title: Gen Comp Endocrinol doi: 10.1006/gcen.2002.7778 contributor: fullname: Peinado – volume: 91 start-page: 2225 year: 2006 ident: 2020071613155272600_R28 article-title: Ghrelin is produced by and directly activates corticotrope cells from adrenocorticotropin-secreting adenomas. publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2006-0235 contributor: fullname: Martinez-Fuentes – volume: 91 start-page: 4769 year: 2006 ident: 2020071613155272600_R4 article-title: High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. publication-title: J Clin Endocrinol Metab doi: 10.1210/jc.2006-1668 contributor: fullname: Daly – volume: 2 start-page: 107 year: 2001 ident: 2020071613155272600_R16 article-title: Rab proteins as membrane organizers. publication-title: Nat Rev Mol Cell Biol doi: 10.1038/35052055 contributor: fullname: Zerial – volume: 71 start-page: 1421 year: 1990 ident: 2020071613155272600_R33 article-title: Clinical, biochemical, and morphological correlates in patients bearing growth hormone-secreting pituitary tumors with or without constitutively active adenylyl cyclase. publication-title: J Clin Endocrinol Metab doi: 10.1210/jcem-71-6-1421 contributor: fullname: Spada – volume: 139 start-page: 516 year: 1998 ident: 2020071613155272600_R11 article-title: Cabergoline in acromegaly: a renewed role for dopamine agonist treatment? publication-title: Eur J Endocrinol doi: 10.1530/eje.0.1390516 contributor: fullname: Cozzi |
SSID | ssj0014453 |
Score | 2.0674305 |
Snippet | Context: Rab proteins regulate the sequential steps of intracellular membrane transport. Alterations of these GTPases and their associated proteins are... CONTEXT:Rab proteins regulate the sequential steps of intracellular membrane transport. Alterations of these GTPases and their associated proteins are emerging... Rab proteins regulate the sequential steps of intracellular membrane transport. Alterations of these GTPases and their associated proteins are emerging as the... Abstract Context: Rab proteins regulate the sequential steps of intracellular membrane transport. Alterations of these GTPases and their associated proteins... CONTEXT: Rab proteins regulate the sequential steps of intracellular membrane transport. Alterations of these GTPases and their associated proteins are... CONTEXTRab proteins regulate the sequential steps of intracellular membrane transport. Alterations of these GTPases and their associated proteins are emerging... |
SourceID | proquest crossref pubmed pascalfrancis wolterskluwer endocrinepress |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 2269 |
SubjectTerms | Acromegaly - etiology Acromegaly - genetics Adenoma - genetics Adenoma - metabolism Adenoma - secretion Biological and medical sciences Cell Membrane - metabolism Endocrinopathies Feeding. Feeding behavior Fundamental and applied biological sciences. Psychology Gene Expression Regulation, Neoplastic - physiology Growth Hormone-Secreting Pituitary Adenoma - genetics Growth Hormone-Secreting Pituitary Adenoma - metabolism Growth Hormone-Secreting Pituitary Adenoma - secretion Human Growth Hormone - secretion Humans Hypothalamus. Hypophysis. Epiphysis (diseases) Medical sciences Non tumoral diseases. Target tissue resistance. Benign neoplasms rab GTP-Binding Proteins - genetics rab GTP-Binding Proteins - metabolism rab GTP-Binding Proteins - physiology RNA, Messenger - metabolism Secretory Vesicles - metabolism Somatotrophs - metabolism Somatotrophs - secretion Tissue Distribution Transfection Tumor Cells, Cultured Vertebrates: anatomy and physiology, studies on body, several organs or systems Vertebrates: endocrinology |
Title | Rab18 Is Reduced in Pituitary Tumors Causing Acromegaly and Its Overexpression Reverts Growth Hormone Hypersecretion |
URI | http://dx.doi.org/10.1210/jc.2007-1893 http://ovidsp.ovid.com/ovidweb.cgi?T=JS&NEWS=n&CSC=Y&PAGE=fulltext&D=ovft&AN=00004678-200806000-00040 https://www.ncbi.nlm.nih.gov/pubmed/18349058 https://search.proquest.com/docview/20847718 https://search.proquest.com/docview/71659081 |
Volume | 93 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9QwFLaGIiEOIHaGpfgAp-Aqi7Mdq0I1UyhIo6nUW2Q7jprSJmiSqDB_lT_Dc-wkE5hKhUs0ytjZvi9vcd6C0Fs_YmkYpJTEPMoI5TwmXMYZiQOXpwHnLMvU0sDxl2B2Qo9O_dPJ5NdG1FJT8z2x3ppX8j-owj7AVWXJ_gOy_UFhB_wGfGELCMP2RhgvGHcia65SPdJGfcjPQaLldQP-_uqntWwuVSedA9a06wH7KvJOgkLQFZfmdWV9hTuWP0worFrKV82ZK7UedVWfWTMwZ0uwQWfgqq4qZV72IJ4PHNsoPdFnWcoiLUEaFUN9p0tZA9suunqFbYevNaikNdF1DPQ69oJlXQh_X-EAhhw2qnBoZWodgBAqraO9XqY3F3lamrSjvGDWov_rSHUugPkLmevMt89NPl7miIZwrD7twCFx2PZeB8WlpXVMfRI6OsC3E-e64aKh7Ug2u7opjNHzrqsbz_ylQ8AJVjpE17ckTmQOOCrV_YcK7QMblUsF85Nzofp7homafQvddkEKqnjDD_NP_ScuSk2JVHNfJitDpVRtnntkL93r8NNR0iqQl1WAa6absGzzkmDMVakCL6pvbd7FhvW0fIDuG7cH72sOP0QTWTxCd45NYMdjVLdUxvMKGyrjvMA9lbGmMjZUxgOVMZALA5XxmMrYUBlrKmNDZTym8hN0cvhxeTAjpiEIETQMbRIKxuIgEiFsUy8KRSakrwokBcyXrk9T8A6Y8jCcLGVOJPzME07osIB7LihT13uKdgo423OEPeo61OZMCvAhwOdgkQCQwHLzQCdRV0zRu-6xJ9913ZdkG7hT9H6MSWJeu-qa4bsjxPpju3brOdEpetNBmICgV1_vWCHLpoIRYEiCJXn9iNAJ_BhM_Cl6prEfrjzyaGz7MJeMyJDoZOukXSmAm1fSNbKDrtqE_eKGT-Eluju8s6_QTr1q5Gsw1mu-25L-N8T-7Ng |
link.rule.ids | 315,783,787,27938,27939 |
linkProvider | Flying Publisher |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Rab18+Is+Reduced+in+Pituitary+Tumors+Causing+Acromegaly+and+Its+Overexpression+Reverts+Growth+Hormone+Hypersecretion&rft.jtitle=The+journal+of+clinical+endocrinology+and+metabolism&rft.au=Vazquez-Martinez%2C+Rafael&rft.au=Martinez-Fuentes%2C+Antonio+J.&rft.au=Pulido%2C+Marina+R.&rft.au=Jimenez-Reina%2C+Luis&rft.date=2008-06-01&rft.issn=0021-972X&rft.eissn=1945-7197&rft.volume=93&rft.issue=6&rft.spage=2269&rft.epage=2276&rft_id=info:doi/10.1210%2Fjc.2007-1893&rft.externalDBID=n%2Fa&rft.externalDocID=10_1210_jc_2007_1893 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-972X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-972X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-972X&client=summon |